Gilead is getting closer to a deal to buy Immunomedics for more than $20 billion – CNBC

0
29
Gilead is getting closer to a deal to buy Immunomedics for more than $20 billion – CNBC

Initial partnership discussions between Gilead Sciences Inc and biopharmaceutical company Immunomedics Inc have shifted to acquisition, which would mean an expansion of Gilead’s portfolio of cancer treatments.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here